VC firm
T1D Fund
Also known as The T1D Fund: A Breakthrough T1D Venture, LLC
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- Boston, MA, United States
- Founded
- 2016
- Assets under management
- $250MStated by firm, as of 2026-09-18Source (opens in a new tab)
- Legal name
- The T1D Fund: A Breakthrough T1D Venture, LLC
Claim, correct or request removal
Record updated 18 September 2026
About
The T1D Fund is an impact investment fund accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D).
Investment approach
- Thesis
- As we grow our portfolio, we seek differentiated, disease-modifying therapeutics and treatments with curative potential for T1D, from disease prevention to reversal, with additional interest in metabolic control and areas of high unmet need.Source (opens in a new tab)
- Takes board seats
- Sometimes
- Board policy
- Post investment, we offer comprehensive support on T1D initiatives and company-wide decisions, from serving in governance roles, including Board and observer seats, to delivering strategic input on pre-clinical and clinical studies, regulatory planning, and competitive landscape analysis.
- Reserves policy
- The T1D Fund’s dollars have more impact today, enabling us to up-tier our investment level by increasing our ownership in subsequent financing rounds to ensure support for T1D as an indication.
- Eligibility
- we seek differentiated, disease-modifying therapeutics and treatments with curative potential for T1D, from disease prevention to reversal, with additional interest in metabolic control and areas of high unmet need.
- Traction requirement
- however, we seek out strong conviction around a clear product thesis that is backed by early validation.
- Investing status notes
- Managing an active portfolio of 25+ companies with over $250 million in assets under management
Locations
- Headquarters
- Boston, MA, United States
Loading relationship preview